Angiotensin I Converting Enzyme Activity in Uranyl Nitrate Induced Acute Renal Failure in Rats

References

• Urinary Enzymes in Clinical and Experimental Medicine, K Jung, H Mattenheimer, U Burchardt. Springer-Verlag, Berlin 1992
   Google Scholar
• Wolf G, Scherberich J E, Nowack A, Stein O, Schoeppe W. Urinary excretion of dipeptidyl aminopeptidase IV in patients with renal disease. Clin Nephrol 1990; 33: 136–142
   PubMedGoogle Scholar
• Price R G. Urinary enzymes, nephrotoxicity and renal disease. Toxicology 1982; 23: 99–134
   PubMed Web of Science ®Google Scholar
• Chouinard S, Viau C, Greselin E. Enzymuria and tubular proteinuria in diabetic rats: a 12-week follow-up study. Ren Fail 1992; 14: 41–47
   PubMed Web of Science ®Google Scholar
• Bomhard E, Maruhn D, Vogel O, Mager H. Determination of urinary glutathione S-transferase and lactate dehydrogenase for differentiation between proximal and distal nephron damage. Arch Toxicol 1990; 64: 269–278
   PubMed Web of Science ®Google Scholar
• Burdmann E A, Andoh T F, Lindsley J, Russell J, Bennett W M, Porter G. Urinary enzymes as biomarkers of renal injury in experimental nephrotoxicity of immunosuppressive drugs. Ren Fail 1994; 16: 161–168
   PubMed Web of Science ®Google Scholar
• Sundberg A GM, Appelkvist E L, Bäckman L, Dallner G. Urinary π-class glutathione transferase as an indicator of tubular damage in the human kidney. Nephron 1994; 67: 308–316
   PubMedGoogle Scholar
• Fauconneau B, Pariat C, Bouquet S, Piriou A, Ingrand P, Courtois P. A comparative study of enzymuria, in the rat, of the drug combinations amikacin/vancomycin and amikacin/teicoplanin. Ren Fail 1993; 15: 469–473
   PubMed Web of Science ®Google Scholar
• Schulz W W, Hagler H K, Buja L M, Erdös E G. Ultrastructural localization of angiotensin I-converting enzyme (EC 3.4.15.1) and neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney. Lab Invest 1988; 59: 789–797
   PubMedGoogle Scholar
• Ikemoto F, Song G B, Tominaga M, Kanayama Y, Yamamoto K. Angiotensin converting enzyme predominates in the inner cortex and medulla of the rat kidney. Biochem Biophys Res Commun 1987; 144: 915–921
   PubMed Web of Science ®Google Scholar
• Baggio B, Favaro S, Cantaro S, Bertazzo L, Frunzio A, Borsatti A. Increased urine angiotensin I converting enzyme activity in patients with upper urinary tract infection. Clin Chim Acta 1981; 109: 211–218
   PubMedGoogle Scholar
• Baggio B, Picolli A, Favaro S, Antonello A, Bertaglia E, Borsatti A. Urinary angiotensin-I-converting enzyme activity as a marker of tubulointerstitial involvement in kidney diseases. Contr Nephrol 1989; 70: 208–212
   PubMedGoogle Scholar
• Pitotti A, Maurich V, Moneghini M, Vianello S. HPLC method for evaluation of urinary angiotensin-converting enzyme: some examples of normal subjects and patients with renal transplantation. J Pharm Biomed Anal 1986; 4: 677–683
   PubMedGoogle Scholar
• Hosojima H, Miyauchi E, Morimoto S. Urinary excretion of angiotensin-converting enzyme in NIDDM patients with nephropathy. Diabetes Care 1989; 12: 580–582
   PubMedGoogle Scholar
• Pedraza-Chaverrí J, Cruz C, Hernández-Pando R, Santana T, Arévalo A E, González L, Tapia E, Peña J C, Panduro A. Angiotensin I-converting enzyme activity in rats with carbon tetrachloride-induced acute renal failure. Ren Fail 1993; 15: 19–26
   PubMed Web of Science ®Google Scholar
• Anthony M L, Gartland K PR, Beddell C R, Lindon J C, Nicholson J K. Studies of the biochemical toxicology of uranyl nitrate in the rat. Arch Toxicol 1994; 68: 43–53
   PubMed Web of Science ®Google Scholar
• Bencosme S A, Stone R S, Latta H, Madden S C. Acute tubular and glomerular lesions in rat kidneys after uranium injury. Arch Pathol 1960; 69: 470–476
   PubMedGoogle Scholar
• Haley D P. Morphologic changes in uranyl nitrate-induced acute renal failure in saline- and water-drinking rats. Lab Invest 1982; 46: 196–208
   PubMed Web of Science ®Google Scholar
• Blantz R C. The mechanism of acute renal failure after uranyl nitrate. J Clin Invest 1975; 55: 621–635
   PubMed Web of Science ®Google Scholar
• Avasthi P S, Evan A P, Hay D. Glomerular endothelial cells in uranyl nitrate-induced acute renal failure in rats. J Clin Invest 1980; 65: 121–127
   Google Scholar
• Pesce A J, Boreisha I, Pollak V E. Rapid differentiation of glomerular and tubular proteinuria by sodium dodecyl sulfate polyacrilamide gel electrophoresis. Clin Chim Acta 1972; 40: 27–34
   PubMed Web of Science ®Google Scholar
• Bernard A. Proteinuria: changes and mechanisms in toxic nephropathies. Toxicology 1991; 21: 373–405
   Google Scholar
• Pedraza-Chaverrí J, Calderón P, Cruz C, Peña J C. Electrophoretic analysis of serum and urinary proteins in rats with aminonucleoside-induced nephrotic syndrome. Ren Fail 1993; 15: 149–155
   PubMed Web of Science ®Google Scholar
• Pedraza-Chaverrí J, Cruz C, Tapia E, Peña J C. Activity of serum enzymes in puromycin aminonucleoside-induced nephrotic syndrome. Ren Fail 1992; 14: 523–531
   PubMed Web of Science ®Google Scholar
• Nagatsu T, Hino M, Fuyamada H, Hayakawa T, Sakakibara S, Nakagawa Y, Takemoto T. New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase. Anal Biochem 1976; 74: 466–476
   PubMed Web of Science ®Google Scholar
• Skhra J, Perusicová J, Stolba P, Stibor V, Páv J. Comparison of N-acetyl-β-glucosaminidase and albuminuria with clinical finding of microangiopathy in type I diabetes mellitus. Clin Chim Acta 1987; 166: 135–141
   Google Scholar
• Wellwood J M, Price R G, Ellis B G, Thompson A E. A note on the practical aspects of the assay of N-acetyl-β-glucosaminidase in human urine. Clin Chim Acta 1976; 69: 85–91
   PubMedGoogle Scholar
• Pedraza-Chaverrí J, Tapia E, Bobadilla N. Ischemia-reperfusion induced acute renal failure in the rat is ameliorated by the spin-trapping agent α-phenyl-N-tert-butyl nitrone (PBN). Ren Fail 1992; 14: 467–471
   PubMed Web of Science ®Google Scholar
• Flamenbaum W, Hamburger R J, Huddleston M L, Kaufman J, McNeil J S, Schwartz J H, Nagle R. The initiation phase of experimental acute renal failure: an evaluation of uranyl nitrate-induced acute renal failure in the rat. Kidney Int 1976; 10: S-115–S-122
   Google Scholar
• Stein J H, Gottschall J, Osgood R W, Ferris T E. Pathophysiology of a nephrotoxic model of acute renal failure. Kidney Int 1975; 8: 27–41
   PubMed Web of Science ®Google Scholar
• Kato A, Hishida A, Kobayashi S, Honda N. Glomerular alterations in experimental oliguric and nonoliguric acute renal failure. Ren Fail 1993; 15: 215–224
   Web of Science ®Google Scholar
• Ortega A, Vilella E, Joven J, Masana L, Camps J. Lack of plasma lipoprotein disturbances in rats with uranyl acetate-induced acute renal failure. Med Sci Res 1991; 19: 525–527
   Google Scholar
• Kato I, Takada Y, Nishimura K, Hiwada K, Kokubu T. Increased urinary excretion of angiotensin converting enzyme in patients with renal diseases. J Clin Chem Clin Biochem 1982; 20: 473–476
   PubMedGoogle Scholar
• Arévalo A E, Ibarra-Rubio M E, Cruz C, Peña J C, Pedraza-Chaverrí J. Angiotensin I-converting enzyme activity in puromycin aminonucleoside-nephrotic syndrome. Clin Chim Acta 1990; 191: 175–184
   PubMed Web of Science ®Google Scholar
• Pedraza-Chaverrí J, Maciel A H, Cruz C, Peña J C. Captopril magnifies the increase in angiotensin I-converting enzyme activity in rats with aminonucleoside nephrosis. Clin Exp Pharmacol Physiol 1992; 19: 439–445
   PubMedGoogle Scholar
• Nortier J, Abramowicz D, Najdovski T, Kinnaert P, Vanherweghem J-L., Goldman M, Deschodt-Lanckman M. Urinary endopeptidase 24.11 as a new marker of proximal tubular injury. Contr Nephrol 1993; 101: 169–176
   Google Scholar
• Fukuda S, Kopple J D. Chronic uremia syndrome in dogs induced with uranyl nitrate. Nephron 1980; 25: 139–143
   PubMed Web of Science ®Google Scholar
• Erdös E G, Skidgel R A. The angiotensin I-converting enzyme. Lab Invest 1987; 56: 345–348
   PubMed Web of Science ®Google Scholar
• Ehlers M RW, Riordan J F. Angiotensin-converting enzyme: biochemistry and molecular biology. Hypertension: Pathophysiology, Diagnosis, and Management, J H Laragh, B M Brenner. Raven Press, New York 1990; 1217–1231
   Google Scholar
• Udupa E GP, Rao N M. Distribution and some properties of sheep (Ovis aries) angiotensin converting enzyme. Biochem Mol Biol Int 1993; 31: 851–860
   Google Scholar
• Naim H Y. Human small intestinal angiotensin-converting enzyme: intracellular transport, secretion and glycosylation. Biochem J 1993; 296: 607–615
   PubMed Web of Science ®Google Scholar
• Beldent V, Michaud A, Wei L, Chauvet M-T., Corvol P. Proteolytic release of human angiotensin-converting enzyme. J Biol Chem 1993; 268: 26428–26434
   PubMed Web of Science ®Google Scholar
• Ramchandran R, Sen G C, Misono K, Sen I. Regulated cleavage-secretion of the membrane-bound angiotensin-converting enzyme. J Biol Chem 1994; 269: 2125–2130
   Google Scholar
• Erman A, Van Dyk D J, Chen-Gal B, Giler I DS, Rosenfeld J B, Boner G. Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats. Eur J Clin Invest 1993; 23: 615–620
   Google Scholar
• Erman A, Chen-Gal B, Zabludowski J, Rosenfeld J B. Cyclosporin A treatment enhances angiotensin converting enzyme activity in lung and serum of rats. J Pharm Pharmacol 1990; 42: 525–527
   PubMed Web of Science ®Google Scholar
• Forslund T, Kouvonen I, Fyhrquist F. Tissue distribution of angiotensin-converting enzyme in the rat: effect of captopril treatment. Acta Pharmacol Toxicol 1984; 54: 124–128
   PubMedGoogle Scholar
• Kokubu T, Ueda E, Ono M, Kawabe T, Hayashi Y, Kan T. Effects of captopril (SQ 14,225) on the reninangiotensin-aldosterone system in normal rats. Eur J Pharmacol 1980; 62: 269–275
   PubMed Web of Science ®Google Scholar